{
    "root": "78cdd870-2e9f-4ee5-b656-f665a71040a0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "GALZIN",
    "value": "20240430",
    "ingredients": [
        {
            "name": "ZINC ACETATE",
            "code": "FM5526K07A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_62984"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "D&C RED NO. 28",
            "code": "767IP0Y5NH"
        }
    ],
    "indications": {
        "text": "zinc acetate therapy indicated maintenance treatment patients wilson \u2019 disease initially treated chelating agent ( : monitoring patients ) .",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended adult dose 50 mg zinc three times daily ( trials ) . since 25 mg t.i.d . also effective dose children 10 years age older women pregnant , may advisable dose zinc 25 mg three times day , long patient compliant therapy . dose raised 50 mg t.i.d . monitoring indicates lessening control ( : monitoring patients ) . patients take zinc acetate empty stomach , least one hour two three hours meals . additional information , .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "galzin\u00ae , zinc acetate capsules ( 25 mg zinc content ) # 1 capsules aqua blue opaque cap body , imprinted `` 93-215 . `` packaged bottles 250 ( ndc 57844-215-52 ) . galzin\u00ae zinc acetate capsules ( 50 mg zinc content ) # 1 capsules orange opaque cap body , imprinted `` 93-208 . `` packaged bottles 250 ( ndc 57844-208-52 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15-30\u00b0c ( 59-86\u00b0f ) . usp controlled room temperature . dispense tight , light-resistant container defined usp , child-resistant closure . rx . revised : 4/2024 distributed : teva pharmaceuticals usa , inc. parsippany , nj 07054 \u00a92024 teva pharmaceuticals usa , inc. rights reserved .",
    "adverseReactions": "zinc acetate capsules contraindicated patients known hypersensitivity components formulation .",
    "indications_original": "Zinc acetate therapy is indicated for maintenance treatment of patients with Wilson\u2019s disease who have been initially treated with a chelating agent (See \n                        PRECAUTIONS: Monitoring Patients).",
    "contraindications_original": "The recommended adult dose is 50 mg as zinc three times daily (See \n                        CLINICAL TRIALS\n                     ).\n                  Since 25 mg t.i.d. is also an effective dose in children 10 years of age or older or in women who are pregnant, it may be advisable to use a dose of zinc to 25 mg three times a day, as long as the patient is compliant with therapy. The dose can be raised to 50 mg t.i.d. if monitoring indicates a lessening of control (see \n                        PRECAUTIONS: Monitoring Patients\n                     ).\n                  Patients should take zinc acetate on an empty stomach, at least one hour before or two to three hours after meals. For additional information, see \n                        PRECAUTIONS\n                     .",
    "warningsAndPrecautions_original": "GALZIN\u00ae, Zinc Acetate Capsules (25 mg zinc content) are #1 capsules with aqua blue opaque cap and body, imprinted \"93-215.\" Packaged in bottles of 250 (NDC 57844-215-52).\n                  GALZIN\u00ae Zinc Acetate Capsules (50 mg zinc content) are #1 capsules with orange opaque cap and body, imprinted \"93-208.\" Packaged in bottles of 250 (NDC 57844-208-52).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15-30\u00b0C (59-86\u00b0F). See USP Controlled Room Temperature. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure.\n                  \n                     Rx only.\n                  \n                  Revised: 4/2024\n                  Distributed by:\nTeva Pharmaceuticals USA, Inc.\nParsippany, NJ 07054\n                  \u00a92024 Teva Pharmaceuticals USA, Inc. All rights reserved.",
    "adverseReactions_original": "Zinc Acetate Capsules are contraindicated in patients with known hypersensitivity to any of the components of the formulation.",
    "drug": [
        {
            "name": "GALZIN",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_62984"
        }
    ]
}